国际肿瘤学杂志››2014,Vol. 41››Issue (11): 833-836.doi:10.3760/cma.j.issn.1673-422X.2014.11.011
出版日期:
2014-12-03发布日期:
2015-01-20通讯作者:
许培权,Email:xupeiquan2003@aliyun.com
Online:
2014-12-03Published:
2015-01-20Contact:
Xu Peiquan, Email: xupeiquan2003@aliyun.com摘要:基质金属蛋白酶(MMP)-9是MMP家族相对分子质量最大的MMP,主要来源于巨噬细胞和中性粒细胞,MMP9与结直肠癌的发生及侵袭转移相关,也可以为结直肠癌的临床预防及治疗提供新的途径
胡俊杰, 许培权. MMP-9与结直肠癌侵袭转移的相关性及临床研究进展[J]. 国际肿瘤学杂志, 2014, 41(11): 833-836.
HU Jun-Jie, XU Pei-Quan. Clinical research progress between MMP-9 and the invasion and metastasis of colorectal cancer[J]. Journal of International Oncology, 2014, 41(11): 833-836.
[1] Tenesa A, Dunlop MG. New insights into the aetiology of colorectal cancer from genomewide association studies[J]. Nat Rev Genet, 2009, 10(6):353358. [2] Zheng X, Wang L, Zhu Y, et al. The SNP rs961253 in 20p12.3 is associated with colorectal cancer risk: a casecontrol study and a metaanalysis of the published literature[J]. PLoS One, 2012, 7:e34625. [3] Gezen C, Kement M, Altuntas YE, et al. Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors[J]. World J Surg Oncol, 2012, 10:39. [4] Vandooren J, PE VDS, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase9 (MMP9): the next decade[J]. Crit Rev Biochem Mol Biol, 2013, 48(3):222272. [5] Groblewska M, Siewko M, Mroczko B, et al. The role of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in the development of esophageal cancer[J]. Folia Histochem Cytobiol, 2012, (50):1219. [6] Garg P1, VijayKumar M, Wang L, et al. Matrix metalloproteinase9mediated tissue injury overrides the protective effect of matrix metalloproteinase2 during colitis[J]. Am J Physiol Gastrointest Liver Physiol, 2009, 296(2):G175184. [7] MotovaliBashi M, Sadeghi M, Hemmati S. Serum MMP9 level associated with initiation and progression steps of breast cancer in the Iranian population[J]. Reprod Sci, 2010, 17(6): 585589. [8] Lin F, Chengyao X, Qingchang L, et al. CRKL promotes lung cancer cell invasion through ERKMMP9 pathway[J]. Mol Carcinog, 2014, In press. [9] Wang Y, Qiu H, Hu W, et al. Overexpression of plateletderived growth factord promotes tumor growth and invasion in endometrial cancer[J]. Int J Mol Sci, 2014, 15(3):47804794. [10] Huang MY, Chen HC, Yang IP, et al. Tumorigenesis and tumor progression related gene expression profiles in colorectal cancer[J]. Cancer Biomark, 2013, 13(4):269279. [11] Dragutinovi′c VV, Radonji′c NV, Petronijevi′c ND. Matrix metalloproteinase2 (MMP2) and 9 (MMP9) in preoperative serum as independent prognostic markers in patients with colorectal cancer.[J]. Mol Cell Biochem, 2011, 355(12):173178. [12] Inafuku Y, Furuhata T, Tayama M, et al. Matrix metalloproteinase2 expression in stromal tissues is a consistent prognostic factor in stage Ⅱ colon cancer[J]. Cancer Sci, 2009, 100(5):852858. [13] Bendardarf R, Buhmeida A, Hilska M, et al. MMP9 (gelatinase B) expression is associated with diseasefree survival and diseasespecific survival in colorectal cancer patients[J]. Cancer Invest, 2010, 28(1):3843. [14] 田小林, 朱小宝, 郭芳, 等. 结肠直肠癌Smad4,MMP9基因表达的相关研究[J]. 癌症进展, 2010, 8(2):183188. [15] Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment[J]. Cell, 2010, 141(1):5267. [16] Roh SA, Choi EY, Cho DH, et al. Growth and invasion of sporadic colorectal adenocarcinomas in terms of genetic change[J]. J Korean Med Sci, 2010, 25(3):353360. [17] 邵惠杰, 张蕾, 符仲标, 等. 结肠腺癌组织中Bmi1 和MMP9 蛋白的表达及其意义[J]. 实用医学杂志, 2011, 27(21):10065725. [18] 侯福涛, 陈子华, 钱立元. BMI1和MMP9在结肠癌细胞中的表达及意义[J]. 中国普通外科杂志, 2010, 19(10):11031106. [19] Lee SJ, Kim WJ, Moon SK. Role of the p38 MAPK signaling pathway in mediating interleukin28Ainduced migration of UMUC3 cells[J]. Int J Mol Med, 2012, 30(4):945952. [20] Yue WY, Chen ZP. Vasculogenic mimie~potential target for tumor therapy[J]. Ai Zheng, 2006, 25(7):914916. [21] WelchReardon KM, Ehsan SM, Wang K, et al .Angiogenic sprouting is regulated by endothelial cell expression of Slug (Snai2)[J]. J Cell Sci, 2014, 38(6):625633. [22] Li CY, Yuan P, Lin SS, et al. Matrix metalloproteinase 9 expression and prognosis in colorectal cancer :a metaanalysis[J]. Tumour Biol, 2013, 34(2):735741. [23] 黄炳臣, 罗春英, 陆海善, 等. 大肠腺癌中HSP27和MMP9的表达及意义[J]. 右江医学, 2010, 38(4):10031383. [24] 武欣, 李坤, 张凡, 等. 大肠癌中CCR7、Lselectin、CD44v6和MMP9表达及其与淋巴转移的关系[J]. 临床与实验病理学杂志, 2013, 29(1):3235. [25] RedondoMuoz J,José Terol M,GarcíaMarco JA,et al.Matrix metalloproteinase9 is upregulated by CCL2/CCR7 interaction via extracelluar signalregulated kinase1/2 signaling and is involved in CCL21driven B cell chronic lymphocytic leukemia cell invasion and migration[J]. Blood, 2008, 111(1):383386. [26] Li J, Sun R, Tao K, et al. The CCL21/CCR7 pathway plays a key role in human colon cancer metastasis through regulation of matrix metalloproteinase9[J]. Dig Liver Dis, 2011, 43(1):4047. [27] Kim HC, Kim YS, Oh HW, et al. Collagen triple helix repeat containing 1 (CTHRC1) acts via ERKdependent induction of MMP9 to promote invasion of colorectal cancer cells.[J]. Oncotarget, 2014, 5(2):51929. [28] Li Y, Li Y, Liu Y, et al. PAX6, a novel target of microRNA7, promotes cellular proliferation and invasion in human colorectal cancer cells[J]. Dig Dis Sci, 2014, 59(3):598606. [29] Hsu TI, Lin SC, Lu PS, et al. MMP7mediated cleavage of nucleolin at Asp255 induces MMP9 expression to promote tumor malignancy[J]. Oncogene, 2014, In press. [30] Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity[J]. Biochim Biophys Acta, 2010, 1803(1):5571. [31] Tseng CN, Huang CF, Cho CL, et al. Brefeldin a effectively inhibits cancer stem celllike properties and MMP9 activity in human colorectal cancer Colo 205 cells[J]. Molecules, 2013, 18(9):1024210253. [32] 周太成, 杨劭宇, 罗宏图, 等. MMP9 介导结肠癌细胞sMICA蛋白脱落的研究[J]. 岭南现代临床外科, 2013, 13(4):315317. |
[1] | 王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369. |
[2] | 张蕊, 褚衍六.基于FIT与肠道菌群的结直肠癌风险评估模型的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 370-375. |
[3] | 高凡, 王萍, 杜超, 褚衍六.肠道菌群与结直肠癌非手术治疗的相关研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 376-381. |
[4] | 王俊毅, 洪楷彬, 纪荣佳, 陈大朝.癌结节对结直肠癌根治性切除术后肝转移的影响[J]. 国际肿瘤学杂志, 2024, 51(5): 280-285. |
[5] | 李书月, 马辰莺, 周菊英, 徐晓婷, 秦颂兵.寡转移非小细胞肺癌的放疗进展[J]. 国际肿瘤学杂志, 2024, 51(3): 170-174. |
[6] | 孙国宝, 杨倩, 庄庆春, 高斌斌, 孙晓刚, 宋伟, 沙丹.结直肠癌肝转移组织病理学生长方式研究进展[J]. 国际肿瘤学杂志, 2024, 51(2): 114-118. |
[7] | 刘德宝, 孙子雯, 鲁守堂, 徐海东.ASB6在结直肠癌组织中的表达及临床意义[J]. 国际肿瘤学杂志, 2023, 50(8): 470-474. |
[8] | 张露, 蒋华, 林州, 马辰莺, 徐晓婷, 王利利, 周菊英.免疫检查点抑制剂治疗复发转移性宫颈癌的疗效及预后分析[J]. 国际肿瘤学杂志, 2023, 50(8): 475-483. |
[9] | 陈卓, 陶俊, 陈琳, 柯晶.外周血miR-194联合粪便miR-143检测对结直肠癌临床筛查的价值[J]. 国际肿瘤学杂志, 2023, 50(5): 268-273. |
[10] | 杨丽蓉, 王羽丰.预测浆液性卵巢癌术后复发远处转移风险机器学习模型的构建[J]. 国际肿瘤学杂志, 2023, 50(4): 220-226. |
[11] | 黄镇, 张蔡羽天, 柯少波, 石薇, 赵文思, 陈永顺.结直肠癌患者术后预后模型的构建[J]. 国际肿瘤学杂志, 2023, 50(3): 157-163. |
[12] | 徐良富, 李袁飞.MSS型结直肠癌肿瘤微环境及免疫联合治疗研究进展[J]. 国际肿瘤学杂志, 2023, 50(3): 186-190. |
[13] | 李雄安, 颜艳艳.丙戊酸镁用于治疗继发癫痫的晚期肺癌脑转移患者1例报道[J]. 国际肿瘤学杂志, 2023, 50(3): 191-192. |
[14] | 马培晗, 张灵敏, 路宁, 张明鑫.麻醉对肝细胞癌复发转移的影响[J]. 国际肿瘤学杂志, 2023, 50(2): 117-121. |
[15] | 刘玉杰, 赵志强, 王子琤.早期结直肠癌患者外周血单个核细胞中TOP2A、ERBB2的水平及其诊断价值[J]. 国际肿瘤学杂志, 2023, 50(12): 717-722. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||